In the pharmaceutical industry, the volume, value, and focus on quality data continues to expand with nearly every organization striving to optimize data for actionable input that will improve their business. With the release of the quality metrics guidance, the U.S. Food and Drug Administration (FDA) is adopting a similar approach by establishing metrics and data analytics capabilities that would optimize their own processes and procedures, and in turn deliver valuable efficiencies for the industry at large.

High-functioning, quality-centric organizations can use the FDA guidance as an impetus for addressing challenges that plague even the most highly-evolved organizations in life sciences.

Read more about the Quality Metrics Guideline in PDF below.